Clinical Trial Update: Phase II Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia [Phase 2]

View source ↗

Summary

Phase II trial evaluating a combination stem cell therapy for critical limb ischemia and severe leg ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• Combination Stem Cell Therapy

Snippet

Sponsor: TCA Cellular Therapy | Conditions: Critical Limb Ischemia, Severe Leg Ischemia | Phase 2 | Status: COMPLETED